Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
Cancer|November 1, 1985
A prospective study of detorubicin in malignant mesotheliomaN Colbert, J M Vannetzel, V Izrael, et al.
The American Review of Respiratory Disease|June 1, 1985
Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complexP Solal-Celigny, L J Couderc, D Herman, et al.
Journal of Virology|February 6, 2009
The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogsZandrea Ambrose, Brian D Herman, Chih-Wei Sheen, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1994
Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imagingC D Santos-Ocampo, S D Herman, M I Travin, et al.
Nucleosides, Nucleotides & Nucleic Acids|May 31, 2011
Synthesis and anti-HIV evaluation of 3'-triazolo nucleosidesVincent Roy, Aleksandr Obikhod, Hong-Wang Zhang, et al.
Progress in Community Health Partnerships : Research, Education, and Action|April 6, 2026
Reducing Stress and Promoting Wellness Among Parents and Service Providers: A University-Community CollaborationLydia F Bierce, Daniel Valerio Montero, Cheryl Finch, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 1, 2020
Auditory Quality-of-Life Measures in Patients With Traumatic Brain Injury and Normal Pure Tone AudiometryRenata M Knoll, Rory J Lubner, Jacob R Brodsky, et al.
The American Journal of Cardiology|March 1, 1997
Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary eventsJ R McClellan, M I Travin, S D Herman, et al.
Respiratory Medicine and Research|September 19, 2019
Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survivalB Asselain, J-R Barrière, C Clarot, et al.
Pharmacology|February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Pageof 38